Centauri Therapeutics is a series a startup. 1 investor tracked. Status: possibledead.
Centauri Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Centauri Therapeutics is focused on the discovery and development of a new class of glycan therapeutics to treat a range of diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.